Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuro-Oncology Anywhere 242: Pilot Study Evaluating Telehealth and In-Person Assessments in Patients With Glioma Receiving Oral Chemotherapy

NCT06625047 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06625047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06625047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuro-Oncology Anywhere 242: Pilot Study Evaluating Telehealth and In-Person Assessments in Patients With Glioma Receiving Oral Chemotherapy
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
October 7, 2024
Completion date
November 12, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, idh-mutant, glioblastoma, glioma, oligodendroglioma, idh-mutant and 1p/19q-codeleted